QQ客服 官方微博 反馈留言

	Tumor cytoreduction results in better response to androgen ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer
	Qin, Xiao-Jian; Ma, Chun-Guang; Ye, Ding-Wei; Yao, Xu-Dong; Zhang, Shi-Lin; Dai, Bo; Zhang, Hai-Liang; Shen, Yi-Jun; Zhu, Yao; Zhu, Yi-Ping
刊名	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
	2012
卷号	30期号:2
关键词	Cytoreductive surgery Hormone sensitive metastatic prostate cancer Hormone therapy Prognosis Transurethral resection of the prostate
ISSN号	1078-1439
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4909539
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Qin, Xiao-Jian,Ma, Chun-Guang,Ye, Ding-Wei,et al. Tumor cytoreduction results in better response to androgen ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,2012,30(2).
APA	Qin, Xiao-Jian.,Ma, Chun-Guang.,Ye, Ding-Wei.,Yao, Xu-Dong.,Zhang, Shi-Lin.,...&Swanson, Gregory P..(2012).Tumor cytoreduction results in better response to androgen ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,30(2).
MLA	Qin, Xiao-Jian,et al."Tumor cytoreduction results in better response to androgen ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer".UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 30.2(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。